SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/18/1/21.06.24 Stock

Warrant

DE000SW8FMW2

End-of-day quote Boerse Frankfurt Warrants
- EUR - Intraday chart for SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/18/1/21.06.24
1 month-56.82%

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Société Générale Société Générale
WKN SW8FMW
ISINDE000SW8FMW2
Date issued 2024-04-02
Strike 18 $
Maturity 2024-06-21 (5 Days)
Parity 1 : 1
Emission price 0.23
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Delta0.29x
Omega 26.31
Premium5.07x
Gearing92.1x
Moneyness 0.9617
Difference Strike 0.84 $
Difference Strike %+4.67%
Spread -0.03
Spread %18.75%
Theoretical value 0.1800
Implied Volatility 40.28 %
Total Loss Probability 71.83 %
Intrinsic value 0.000000
Present value 0.1800
Break even 18.19 €
Theta-0.17x
Vega0.01x
Rho0x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.16 USD
Average target price
18.34 USD
Spread / Average Target
+6.85%
Consensus